【摘要】 目的观察巴曲酶及阿加曲班治疗急性进展性脑梗死的效果。方法收集150名急性进展性脑梗死患者,随机分为常规组,巴曲酶组、阿加曲班组,观察治疗前后生化指标及不良反应。结果经治疗,巴曲酶组有效率52.0%,阿加曲班组有效率为72.0%,都好于常规组28.0%,差异有统计学意义(P<0.05)。结论巴曲酶、阿加曲班治疗急性进展性脑梗死是安全有效的,阿加曲班更为有效。更多还原

【Abstract】 Objective To observe the effect of the treatment of acute progressive cerebral infarction acute progressive cerebral infarction. Methods 150 cases of acute progressive cerebral infarction patients into normal group, batroxobin group, argatroban observed reactions. Results Batroxobin group have efficiency 52.0% and argatroban group effective rate was 72.0%, significantly better than the control group 28.0%, the difference was statistically significant(P<0.05). Conclusion The treatment of acute progressive cerebral infarction is safe and effective.更多还原